UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K 1375 West Fulton Street, Suite 1300 Chicago, Illinois 60607 (Address of principal executive offices, including zip code) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2025 XERIS BIOPHARMA HOLDINGS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) Delaware 001-40880 87-10 ...